NCT06558201Enrolling by invitation
Open Label Extension Study of NCT06221852
Open Label Extension Study of NCT06221852 of the Ketogenic Diet in Participants With First Episode Bipolar Disorder.
Source: ClinicalTrials.gov · Last updated 17 Aug 2026
Brief summary (registry, in English)
This is a 12-week open-label extension study for participants completing study NCT06221852.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 14 Aug 2024
- Start date
- 28 Aug 2024
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Mclean Hospital
- Diseases
- Schizophrenia, Bipolar disorder
- NCT number
- NCT06558201
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 28 Aug 2024 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- -No longer meeting original entry criteria from the randomized 12-week study of NCT06221852.
Who the study is looking for
- Participants who met original entry criteria in, and completed, the randomized 12-week study of NCT06221852.
Age in the registry: 18 years to 45 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| McLean Hospital Coordinator of this site? Confirm its status | Belmont | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.